irbesartan hydrochlorothiazide zentiva (previously irbesartan hydrochlorothiazide winthrop)
sanofi-aventis groupe - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
apo-irbesartan hctz 300/25 irbesartan and hydrochlorothiazide 300/25mg tablet blister pack
arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; croscarmellose sodium; magnesium stearate; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000; iron oxide black - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
irbesartan hctz amneal 300/25 irbesartan hydrochlorothiazide 300/25 mg tablets blister pack
amneal pharma australia pty ltd - hydrochlorothiazide,irbesartan -
irbesartan hctz amneal 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack
amneal pharma australia pty ltd - hydrochlorothiazide,irbesartan -
irbesartan hctz amneal 150/12.5 irbesartan hydrochlorothiazide 150/12.5 mg tablets blister pack
amneal pharma australia pty ltd - hydrochlorothiazide,irbesartan -
irbesartan hydrochlorothiazide bms
bristol-myers squibb pharma eeig - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.this fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone (see section 5.1).
irbesartan/hydrochlorothiazide teva
teva b.v. - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed-dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
irbesartan/ hydrochlorothiazide aurobindo 150mg/12.5mg film-coated tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, irbesartan - film-coated tablet - hydrochlorothiazide 12.5 mg irbesartan 150 mg - agents acting on the renin-angiotensin system
irbesartan/ hydrochlorothiazide aurobindo 300mg/12.5mg film-coated tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, irbesartan - film-coated tablet - hydrochlorothiazide 12.5 mg irbesartan 300 mg - agents acting on the renin-angiotensin system
stada irbesartan hct 300/25 irbesartan/hydrochlorothiazide 300 mg/25 mg tablet blister
medis pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; hydrogenated castor oil; microcrystalline cellulose; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium; povidone - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.